CTOR — CITIUS ONCOLOGY INC

Ownership history in VANGUARD GROUP INC  ·  2 quarters on record

This page tracks every 13F SEC filing in which VANGUARD GROUP INC reported a position in CITIUS ONCOLOGY INC (CTOR). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 ADDED 596,997 +416,829 +231.4% 0.00% $597K $1.00
2025 Q3 INITIATED 180,168 — — 0.00% $366K $2.03
% of Fund (quarterly)    CTOR price (monthly, adj. close)

Other funds also holding CTOR

As of 2025 Q4 — sorted by position size

ARMISTICE CAPITAL, LLC 3Y 7Y 0.07% IFP Advisors, Inc 3Y 7Y 0.0% XTX Topco Ltd 3Y 0.0% TWO SIGMA SECURITIES, LLC 3Y 7Y 0.0% OMERS ADMINISTRATION Corp 3Y 7Y 0.0% Arkadios Wealth Advisors 3Y 0.0% Versant Capital Management, Inc 3Y 7Y 0.0% TWO SIGMA INVESTMENTS, LP 3Y 7Y 0.0% OSAIC HOLDINGS, INC. 3Y 0.0% GEODE CAPITAL MANAGEMENT, LLC 3Y 7Y 0.0%
← Back to VANGUARD GROUP INC Holdings